Cardiovascular Devices Market Size By Device Type (Cardiac Ablation Devices {Radiofrequency Ablators, Electric Ablators, Cryoablation Devices, Ultrasound Devices}, Left Atrial Appendage (LAA) Closure Devices {Endocardial LAA Closure Devices, Epicardial LAA Closure Devices}, Endoscopic Vessel Harvesting (EVH) Devices {EVH Systems, Endoscopes, Accessories}), By End-use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: Feb 2021  |  Report ID: GMI4949  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 206   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry trends

Cardiovascular Devices Market size was valued at over USD 3 billion in 2020 and is expected to witness around 16.7% CAGR from 2021 to 2027. Incidence of COVID-19 has impacted the industry with procedure deferrals during initial period of pandemic. Risk of infection during surgical procedures and high burden of COVID-19 related hospital admissions has primarily influenced the procedural volume. However, high risk of fibrillation among the patient suffering through COVID-19 and urgent care admissions for patients with heart conditions with decrease in incidence of coronavirus infection has driven the product demand. Moreover, collaborative strategies of government and companies to maintain cardiac care amid pandemic has sustained industrial revenue. Thus, the industry has experienced moderate impact of coronavirus outbreak and will continue to showcase significant growth with declining prevalence of COVID-19.
 

Cardiovascular Devices Market

Get more details on this report - Request Free Sample PDF
 

Increasing awareness and demand for minimally invasive surgeries will stimulate the market growth in the coming years. Benefits such as small incisions, reduced risk of infection and relatively less time-consumption are the factors that fuel the patient preference for these procedures. Furthermore, technological advancements in cardiovascular devices offers effective solutions for such minimally invasive procedures. With continuous developments in the technology towards miniaturization, material biocompatibility of implantable and advanced navigation devices, the market is anticipated to observe significant growth over the forecast period. 
 

Cardiovascular Devices Market Report Coverage
Report Coverage Details
Base Year: 2020 Market Size in 2020: USD 3.3 Billion
Historical Data for: 2016 to 2020 Forecast Period: 2021 to 2027
Forecast Period 2021 to 2027 CAGR: 16.7% 2027 Value Projection: USD 10.3 Billion
Pages: 206 Tables, Charts & Figures: 317
Geographies covered (18): U.S., Canada, Germany, UK, France, Spain, Italy, China, Japan, Australia, South Korea, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE
Segments covered: Device Type, and End-use
Companies covered (20): Abbott Laboratories, AngioDynamics, Inc., AtriCure, Inc., Biosense Webster (Johnson & Johnson), Boston Scientific Corporation, Biotronik SE & Co. KG, CardioFocus, Getinge AB Japan Lifeline Co. Ltd., KARL STORZ, Lepu Medical Technology(Beijing) Co. Ltd., Lifetech Scientific, LivaNova PLC, MicroPort Scientific Corporation, Medical Instruments Spa, Medtronic Occlutech, Saphena Medical, Stereotaxis, Inc., Terumo Corporation
Growth Drivers:
  • Increasing number of patients suffering from cardiovascular diseases
  • Growing geriatric population contributing to global cardiovascular disease burden
  • Increasing government initiatives
  • Technological advancements in cardiovascular devices
  • Rising demand for minimally invasive procedures
Pitfalls & Challenges:
  • High risk associated with cardiac procedures
  • Stringent regulatory scenario

Get more details on this report - Request Free Sample PDF
 

Favourable government initiatives facilitating research in cardiovascular medicine will foster the market expansion

The cardiovascular devices market is projected to showcase exponential growth with the high adoption of advanced technologies to cater to rising disease burden. Several factors including prevalence of lifestyle disorders with increasing consumption of alcohol, smoking and reduced physical activities along with environmental changes are predicted to boost the procedural volume over the coming years. This will considerably augment the demand for cardiovascular devices. Along with significant disease prevalence, supportive government initiatives and funding facilitates research in the field and stimulates the industry growth potential.
 

Launch of advanced ablation devices catering to increasing procedural volume for atrial fibrillation will spur the market revenue

Cardiovascular Devices Market Share

Get more details on this report - Request Free Sample PDF
 

Cardiac ablation devices segment dominated more than 72% of the market share in 2020. Growing prevalence of atrial fibrillation (AF) is driving the demand for minimally invasive ablation procedure. Innovations in ablation devices focusing on maximization of success rate and outcome is further impacting procedure and device adoption. Single shot pulmonary vein isolation modalities, prominently in the form of cryoballoon have impeled procedural efficiency. In addition, improved imaging and navigation systems substantially enhances safety and efficacy during AF ablation. Thus, high acceptance of ablation devices with increased procedural demand will influence segment growth in the coming years.
 

Infrastructure development in hospitals, propelling patient preference for numerous heart surgeries will simulate the cardiovascular devices market value

Hospital end-use segment accounted for USD 1.5 billion in 2020. Wide range of surgeries such as open-heart surgery, interventional cardiac procedures, and occlusion procedures among others are performed in hospital cardiac departments. Increasing expenditure on healthcare infrastructure in emerging economies has resulted in usage of advanced cardiac devices in these facilities. Also, several hospitals in emerging countries are funding to expand the cardiology unit. Thus, owing to the high procedural volume and preference for well-equipped facilities by patients, the segment will showcase robust growth in the coming years.
 

Presence of major providers and new firms will create substantial demand for cardiovascular devices in the North America Region

North America Cardiovascular Devices Market

Get more details on this report - Request Free Sample PDF
 

North America cardiovascular devices market accounted for 40% of revenue share in 2020. Presence of leading players focusing on product innovation and significant portion of expenditure on research and development contributes to the regional growth. Due to greater awareness and acceptance of innovative technologies in the U.S., market leaders register momentous growth potential.
 

According to the Centers for Disease Control and Prevention, over 454,000 hospitalizations, seeking primary diagnosis for atrial fibrillation are reported each year in the U.S. Increasing hospital admissions and advanced infrastructure in facilities create revenue opportunities for the market. Such contributing factors are leading to increased product sales that will ultimately impel the growth for North America region.
 

Prominent industry participants are extensively focusing on product innovation and collaborations to sustain their competitive advantage

Some of the leading companies operating in the market include Abbott Laboratories (St. Jude Medical), Biosense Webster (Johnson & Johnson), Boston Scientific Corporation, Medtronic plc and Terumo Medical Corporation among others. These industry players are adopting various organic as well as inorganic growth strategies to obtain competitive advantage and strengthen their market position.
 

Some of the recent industry developments:

  • In January 2021, CardioFocus expanded its distribution across Spain and Portugal by extending its partnership with MicroPort CRM in France. This will lead to geographical expansion, thus offering revenue growth opportunities to the company.
     
  • In December 2020, Biotronik announced the CE Mark approval for its gold-tipped, force sensing ablation catheter. The product approval has assisted the company in expanding its product portfolio.
     
  • In August 2020, Biosense Webster announced the CE Mark approval for its powered, short-duration ablation catheter, QDOT MICRO. This has assisted the company in portfolio expansion, thereby stimulating its revenue growth.
     

The cardiovascular devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:
 

Market, By Device Type

  • Cardiac ablation devices
  • Radiofrequency ablators
  • Electric ablators
  • Cryoablation devices
  • Ultrasound devices
  • Others
  • Left atrial appendage closure devices
  • Endocardial LAA closure devices
  • Epicardial LAA closure devices
  • Endoscopic vessel harvesting devices
  • EVH systems
  • Endoscopes
  • Accessories

Market, By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Cardiac centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
       

Frequently Asked Questions (FAQ) :

Cardiovascular devices market had generated USD 3 billion in revenue during 2020 and will register a 16.7% CAGR over 2021-2027.
Cardiac ablation devices dominated the market with a 72% revenue share in 2020 and will witness a robust demand due to the growing prevalence of atrial fibrillation (AF).
Cardiovascular devices market generated USD 1.5 billion from hospitals in 2020 and will show similar trends in the future with increasing healthcare infrastructure investments in emerging countries.
North America cardiovascular devices industry held 40% of global market share in 2020 and will witness notable growth led by the presence of leading players focusing on product innovation.

 Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Premium Report Details

  • Published Date: Feb 2021
  • Pages: 206
  • Tables: 303
  • Charts / Figures: 14
  • Companies covered: 20
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market, request a free sample now

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X